Skip to main content
Clinical Trials/NCT00823017
NCT00823017WithdrawnPhase 1

The Effect of Patient-Preferred Music, Relaxation Music, and Standard Care Environment on Patients in Intensive Care Units

MetroHealth Medical Center2 sites in 1 countryStarted: July 2006Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Withdrawn
Locations
2
Primary Endpoint
Pain level

Study Overview

Brief Summary

The purpose of this study is to investigate the effects of patient-preferred music, relaxation music, and standard care environment on patients in intensive care units.

Detailed Description

This study is a prospective randomized clinical trial. The purpose of this 4-stage study is to explore the effects of patient-preferred music, relaxation music, and standard care environment on patients in intensive care units.

Stage 1: Recommendation of relaxation music by music therapists who serves as expert panel

Stage 2: Analysis of recommended relaxation music by music therapists

Stage 3: Content validation of relaxation music by healthy adults

Stage 4: Comparison of patients' physiological, psychological, and biological responses to patient-preferred music, relaxation music, and standard care environment

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Communicative (non-intubated, non-sedated)
  • At least three days of admission (excluding day of admission)
  • 18 years or older
  • Mean arterial blood pressure equal or greater than 65 throughout study
  • Mean SpO2 equal or greater than 90 throughout study
  • Glasgow coma scale equal or greater than 14
  • Bilirubin level less than 5
  • Ammonia level less than 1
  • Hematocrit level greater than 15
  • BUN equal or less than 100
  • Non-communicative (intubated, sedated)
  • At least three days of admission (excluding day of admission)
  • 18 years or older
  • Mean arterial blood pressure equal or greater than 65 throughout study
  • Mean SpO2 equal or greater than 90 throughout study
  • Glasgow coma scale equal or greater than 10
  • Bilirubin level less than 5
  • Ammonia level less than 1
  • Hematocrit level greater than 15
  • BUN equal or less than 100

Exclusion Criteria

  • Communicative (non-intubated, non-sedated)
  • Patients admitted for or less than 3 days
  • Patients with hearing impairments
  • Patients with neurological impairments that might impair their ability to process information
  • Patients on glucocorticoid medications
  • Patients with mental health diagnoses and currently experiencing active psychosis such as hallucinations and/or delusions
  • Patient's condition altered dramatically over the 3 days of research
  • Non-communicative (intubated, sedated)
  • Patients admitted for or less than 3 days
  • Patients with hearing impairments
  • Patients with neurological impairments that might impair their ability to process information
  • Patients on glucocorticoid medications
  • Patients with mental health diagnoses and currently experiencing active psychosis such as hallucinations and/or delusions
  • Patient's condition altered dramatically over the 3 days of research

Outcomes

Primary Outcomes

Pain level

Time Frame: 4 data points throughout 1-hour intervention

Anxiety level

Time Frame: 4 data points throughout 1-hour intervention

Respiration rate

Time Frame: 4 data points throughout 1-hour intervention

Comfort level

Time Frame: 4 data points throughout 1-hour intervention

Saliva/Serum Immunoglobulin A Concentration

Time Frame: 3 data points throughout 1-hour intervention

Heart rate

Time Frame: 4 data points throughout 1-hour intervention

Blood pressure

Time Frame: 4 data points throughout 1-hour intervention

Saliva/Serum Cortisol level

Time Frame: 3 data points throughout 1-hour intervention

Secondary Outcomes

  • Psychophysical properties of relaxation music(1 rating)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Charles J. Yowler MD

Professor, Case Western Reserve University School of Medicine

MetroHealth Medical Center

Study Sites (2)

Loading locations...

Similar Trials